Ascentage Pharma Group International (ASPHF:OTCMKTS)
$8.48 0.00 (0.00%)
Analysed Ascentage Pharma Group International (ASPHF:OTCMKTS) News Sources
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
The Manila Times
Piper Sandler Sticks to Its Buy Rating for Crescent Biopharma (CBIO)
The Globe and Mail
The Forttuna Group marks one year of impact with the Forttuna Global 100
Forbes India
Making complex and innovative products at scale, the next frontier, say pharma chiefs
The Hindu BusinessLine
90% of country’s cough syrup units inspected; 850 CAPA notices issued in quality crackdown: DCGI
The Indian Express
Novartis AG to exit Novartis India with 70.68% stake sale; open offer announced at Rs 860.64 per share
The Financial Express
Novartis India shares zoom on Swiss parent’s ₹1,446 cr. exit plan
The Hindu
Novartis AG to exit listed India unit in $159 mn deal with ChrysCapital
Business Standard
Emerging Entrepreneurs Making A Strong Impact Across Industries
ABP News on MSN
Opinion The world’s pharmacy has a challenge — shifting from volume to value
The Indian Express
What is the current price of Ascentage Pharma Group International (ASPHF:OTCMKTS)?
The current price of Ascentage Pharma Group International (ASPHF:OTCMKTS) is $8.48.
Ascentage Pharma Group International (ASPHF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Ascentage Pharma Group International (ASPHF:OTCMKTS) since the previous trading day is $0.00.
Ascentage Pharma Group International (ASPHF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Ascentage Pharma Group International (ASPHF:OTCMKTS) since the previous trading day is 0.00%.
What is This Week's average sentiment score for Ascentage Pharma Group International (ASPHF:OTCMKTS)?
This Week's average sentiment score for Ascentage Pharma Group International (ASPHF:OTCMKTS) is 61 out of 100.
What is This Week's average sentiment for Ascentage Pharma Group International (ASPHF:OTCMKTS)?
This Week's sentiment for Ascentage Pharma Group International (ASPHF:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.